通过多学科的方法解决老年人与药物相关的问题在韩国医院多药计划的医院化多药学项目中
Hyunwoo Chae1, Young-Mi Ah2, Sunmee Jang3
1College of Pharmacy, Seoul National University, Seoul, Korea.
Yonsei medical journal
|January 21, 2026
概括
医院团队有效地管理老年人多药,识别药物问题并进行必要的处方更改. 针对非常老年患者和服用多种药物的患者,可以提高计划的效率.
科学领域:
- 老年医学 老年医学
- 临床药房 临床药房
- 公共卫生 公共卫生
背景情况:
- 多药性是老年人的主要健康问题.
- 一个国家医院的多药管理计划 (PMP) 被实施.
- 这项研究评估了PMP的初始性能,并确定了与药物相关问题 (MRPs) 相关的因素.
研究的目的:
- 评估一个多学科的多药店管理计划 (PMP) 的有效性.
- 确定与药物相关问题 (MRPs) 相关的因素,导致老年人处方变化.
- 评估基于国家医院的PMP的绩效.
主要方法:
- 对33家医院1740名患者的2021年PMP数据的回顾性分析.
- 检查药物审查和干预结果记录,以及患者人口统计数据.
- 多变量后勤回归用于识别处方修改的预测因素.
主要成果:
- 与药物相关的问题 (MRPs) 在73.5%的患者中被发现,平均每患者2.7人.
- 常见的MRP包括潜在不合适的药物 (58.7%),药物相互作用 (46.9%) 和不良药物反应 (26.2%).
- 预测处方修改的因素包括晚年 (≥85岁),高药物数量 (≥20) 和特定药物类别的使用.
结论:
- 多学科的医院团队成功地识别和解决了韩国老年人多药疗法的MRPs.
- 优化PMP效率可以通过准高风险子组来实现,例如非常老年人和那些药物负担很高的人.
- 需要进一步研究PMP干预措施的长期临床和经济结果.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


